Advances in ATM, ATR, WEE1, and CHK1/2 inhibitors in the treatment of PARP inhibitor-resistant ovarian cancer
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2023-12-01
|
Series: | Cancer Biology & Medicine |
Online Access: | https://www.cancerbiomed.org/content/20/12/915 |